FRET

By Ben Butkus
Biosearch Technologies said today that it has acquired worldwide rights from the University of Medicine and Dentistry of New Jersey to patents covering "non-FRET" nucleic acid probe technology.

The new test will be based on real-time PCR using fluorescence resonance energy transfer probes for detection.

The scientist has founded consulting firm Perpetual Genomics to license the technology, which would be a "true universal library" of extremely short FRET-based PCR probes that could allow manufacturers to sell probes fractionally and significantly reduce their cost.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.